ArticleMediators of inflammation2019

Adalimumab Accounts for Long-Term Control of Noninfectious Uveitis Also in the Absence of Concomitant DMARD Treatment: A Multicenter Retrospective Study.

Alice Bitossi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.